EA201990883A1 - BERBERIN SALTS, UROSODESOXYCHOLIC ACID SALTS AND THEIR COMBINATIONS, METHODS FOR PRODUCING AND USE - Google Patents

BERBERIN SALTS, UROSODESOXYCHOLIC ACID SALTS AND THEIR COMBINATIONS, METHODS FOR PRODUCING AND USE

Info

Publication number
EA201990883A1
EA201990883A1 EA201990883A EA201990883A EA201990883A1 EA 201990883 A1 EA201990883 A1 EA 201990883A1 EA 201990883 A EA201990883 A EA 201990883A EA 201990883 A EA201990883 A EA 201990883A EA 201990883 A1 EA201990883 A1 EA 201990883A1
Authority
EA
Eurasian Patent Office
Prior art keywords
diseases
liver
disorders
methods
diabetes
Prior art date
Application number
EA201990883A
Other languages
Russian (ru)
Inventor
Липин Лю
Original Assignee
Шэньчжэнь Хайтайд Биофармасьютикал, Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шэньчжэнь Хайтайд Биофармасьютикал, Лтд. filed Critical Шэньчжэнь Хайтайд Биофармасьютикал, Лтд.
Publication of EA201990883A1 publication Critical patent/EA201990883A1/en

Links

Abstract

Предложены композиции берберина в комбинации с фармацевтически активными органическими кислотами и способы их применения для лечения различных заболеваний или расстройств; соединения, полученные на основе берберина и фармацевтически активных органических кислот и на основе урсодезоксихолевой кислоты и фармацевтически активных органических оснований, и фармацевтические композиции и способы их получения и терапевтического применения для лечения и/или предотвращения различных заболеваний или расстройств. Соединения и фармацевтические композиции согласно настоящему изобретению можно применять для лечения различных заболеваний или расстройств, таких как диабет, осложнения диабета, дислипидемия, гиперлипидемия, ожирение, метаболические синдромы, нарушения метаболизма, предшествующие диабету, атеросклероз, сердечные заболевания, нейродегенеративные заболевания, саркопения, мышечная атрофия, воспаление, рак и заболевания и состояния печени, такие как жировой гепатоз, неалкогольная жировая болезнь печени, неалкогольный стеатогепатит, холестатические заболевания печени или заболевание печени "трансплантат против хозяина". Соединения также можно применять для улучшения функций печени при хронических вирусных заболеваниях печени и алкогольных заболеваниях печени.Berberine compositions in combination with pharmaceutically active organic acids and methods for their use in the treatment of various diseases or disorders are provided; compounds derived from berberine and pharmaceutically active organic acids and based on ursodeoxycholic acid and pharmaceutically active organic bases, and pharmaceutical compositions and methods for their preparation and therapeutic use for the treatment and / or prevention of various diseases or disorders. The compounds and pharmaceutical compositions of the present invention can be used to treat various diseases or disorders, such as diabetes, complications of diabetes, dyslipidemia, hyperlipidemia, obesity, metabolic syndromes, metabolic disorders, previous diabetes, atherosclerosis, heart disease, neurodegenerative diseases, sarcopenia, muscle atrophy , inflammation, cancer and diseases and conditions of the liver, such as fatty hepatosis, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, cholestatic liver disease or graft versus host disease. The compounds can also be used to improve liver function in chronic viral liver diseases and alcoholic liver diseases.

EA201990883A 2015-03-04 2015-07-28 BERBERIN SALTS, UROSODESOXYCHOLIC ACID SALTS AND THEIR COMBINATIONS, METHODS FOR PRODUCING AND USE EA201990883A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562128077P 2015-03-04 2015-03-04

Publications (1)

Publication Number Publication Date
EA201990883A1 true EA201990883A1 (en) 2019-12-30

Family

ID=69061872

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990883A EA201990883A1 (en) 2015-03-04 2015-07-28 BERBERIN SALTS, UROSODESOXYCHOLIC ACID SALTS AND THEIR COMBINATIONS, METHODS FOR PRODUCING AND USE

Country Status (1)

Country Link
EA (1) EA201990883A1 (en)

Similar Documents

Publication Publication Date Title
EA201790124A1 (en) SALT BERBERIN, SALT URSODEZOXYCHOLEIC ACID AND THEIR COMBINATION, METHODS OF OBTAINING AND APPLICATION
EP4292588A3 (en) Administration of deuterated cftr potentiators
EA201892395A1 (en) DRUG COMPOSITIONS OF LSD1 INHIBITOR
EA201992607A1 (en) SOLID FORMS OF UBERODESOXYCHOLATE BERBERIN, THEIR COMPOSITIONS AND METHODS
WO2017087608A8 (en) Modulators of ror-gamma
EA201792541A3 (en) INHIBITORS OF BILATERIC ACIDS RECIRCULATION FOR THE TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC DISEASE OF THE LIVER
BR112016021985A8 (en) pharmaceutical formulation and compound
WO2016161342A3 (en) Nitrobenzyl derivatives of anti-cancer agents
BR112014006220A2 (en) galacto-ramnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic liver fat disease
EA202191050A1 (en) PFKFB3 INHIBITORS AND THEIR USE
EA201890859A1 (en) PREVENTION, TREATMENT AND TREATMENT OF DEVELOPMENT OF DISEASE WITH THE APPLICATION OF THERAPEUTICALLY EFFECTIVE QUANTITIES OF ACTIVATED FATTY ACIDS
BR112015020600A2 (en) pharmaceutical composition, method for treating and / or ameliorating non-alcoholic liver fat disease and use of the composition
RU2018136872A (en) COMPOSITIONS CONTAINING 15-OH EPA AND WAYS OF THEIR APPLICATION
BR112018005905A2 (en) ? compound, pharmaceutical composition, methods to prevent or treat a disease or condition, organ damage, hepatotoxicity and fatty liver, and, use of a compound?
EA201391737A1 (en) NEW CONNECTIONS AS DIACYLGLYCEROLACILTRANSFERASE INHIBITORS
WO2016090024A3 (en) Combination therapy for treatment of cancer
BR112013021566A2 (en) compound of formula, or a pharmaceutically acceptable salt or adduct thereof and method of preventing and / or treating an individual comprising administering to said individual a therapeutically effective amount of a compound of formula
AU2017258781A1 (en) Di-substituted pyrazole compounds for the treatment of diseases
EA201792530A1 (en) ORAL COMPOSITION OF TELECOXIB FOR THE TREATMENT OF PAIN
EA201792341A1 (en) DERIVATIVES OF PYRAZOLA SUITABLE AS INHIBITOR PROTEINS ACTIVATING 5-LIPOXYGENASE (FLAP)
EA201792565A1 (en) BISAMID DERIVATIVE OF DICARBONIC ACID AS A MEANS STIMULATING TISSUE REGENERATION AND RESTORING DECREASED TISSUE FUNCTIONS
JP2019529569A5 (en)
EA201990883A1 (en) BERBERIN SALTS, UROSODESOXYCHOLIC ACID SALTS AND THEIR COMBINATIONS, METHODS FOR PRODUCING AND USE
BR112022012499A2 (en) PEPTIDE, COMPOSITION, METHODS TO TREAT A PATIENT AND TO TREAT DISEASE, AND, USE OF A PEPTIDE
WO2014130678A3 (en) Methods and compositions of treating and preventing intestinal injury and diseases related to tight junction dysfunction